News
These new supplemental products are offering similar benefits to drugs like Ozempic - but experts say it may be a placebo ...
GLP-1 Plus by Advanced BioNutritionals enters the spotlight with a patented dihydroberberine (DHB) formula in 2025, reflecting rising interest in GLP-1 alternatives and non-injection hunger support ...
12h
MarketBeat on MSNTrump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli Lilly
This week, drugmakers had a scare when President Trump threatened to levy tariffs of up to 250% on imported pharmaceuticals.
Eli Lilly says their obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for ...
Embecta Corp (EMBC) reports strong third-quarter growth and strategic advancements, while navigating geopolitical and market ...
Ideals of what beauty is, exacerbated by social media and artificial intelligence, has the potential to harm women's health – ...
The Indian pharmaceutical market (IPM) registered a growth of 7.9 percent in July 2025, and cardiac and anti-diabetes therapy ...
In a letter sent to Harvard President Alan M. Garber on Friday, Commerce Secretary Howard Lutnick alleges the university ...
Ali Eastburn was looking forward to her son's wedding when her side-effects from weight loss drugs went from bad to worse ...
Knowledge Nugget: What Lancet study reveals about Diabetes in India and why it matters for UPSC exam
One in five older Indian adults had diabetes in 2019, says a Lancet study. What are the key highlights of the study? What is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results